Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Tissue Kallikrein 1 and Alternative Complement Pathway Activation in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Sarah E Sartain, Paula Jacobi, Virginie Qian, Mrinal Ranjan, Saleh Bhar, Ang Li, Andrew Yee

Blood (2024) 144 (Supplement 1): 2604.

https://doi.org/10.1182/blood-2024-205948

Published: 2024

Journal Articles

Functional Assessment of VWD Type 2N Variants Using Mammalian Cell Displayed Surface-Tethered Von Willebrand Factor

Kerry W Lannert, Shelley N Fletcher, Nicholas A Popp, Pamela A Christopherson, Daniel J Hampshire, Doug M Fowler, Andrew Yee, Jill M Johnsen

Blood (2023) 142 (Supplement 1): 2604.

https://doi.org/10.1182/blood-2023-190788

Published: 2023

Journal Articles

Keeping it together

Andrew Yee

Blood (2023) 141 (12): 1374–1376.

https://doi.org/10.1182/blood.2022019547

Published: 2023

Journal Articles

Phage Display Functionally Defines Variants in the Von Willebrand Factor Platelet Binding Domain

Andrew Yee, Melda Arslantas Guzel, Manhong Dai, Fan Meng, David Ginsburg

Blood (2021) 138 (Supplement 1): 1033.

https://doi.org/10.1182/blood-2021-151347

Published: 2021

Journal Articles

Development of Platforms to Phenotype Variants of Uncertain Significance in VWF

Andrew Yee, PhD, Manhong Dai, Colin Kretz, PhD, Fan Meng, PhD, David Ginsburg, MD

Blood (2016) 128 (22): 1386.

https://doi.org/10.1182/blood.V128.22.1386.1386

Published: 2016

Journal Articles

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Blood (2016) 128 (22): 976.

https://doi.org/10.1182/blood.V128.22.976.976

Published: 2016

Journal Articles

Comprehensive Genetic Interrogation of Circulating Multiple Myeloma Cells at Single Cell Resolution

Jens G Lohr, MD PhD, Sora Kim, Joshua Gould, Birgit Knoechel, MD PhD, Yotam Drier, PhD, Daniel Gray, PhD, Nicole Birrer, Bang Wong, Gavin Ha, PhD, Cheng-Zhong Zhang, PhD, Guangwu Guo, Matthew Meyerson, MD PhD, Andrew Yee, Jesse Boehm, PhD, Noopur Raje, MD, Todd R. Golub, MD

Blood (2016) 128 (22): 800.

https://doi.org/10.1182/blood.V128.22.800.800

Published: 2016

Journal Articles

Vemurafenib (VEM) in Relapsed Refractory Multiple Myeloma Harboring BRAF V600 Mutations (V600m): A Cohort of the Histology-Independent VE-Basket Study

Noopur Raje, Ian Chau, David M. Hyman, Vincent Ribrag, Jean-Yves Blay, Josep Tabernero, Maria Elena Elez-Fernandez, Jürgen S. Wolf, Florin Sirzen, Andrew Yee, Jason Faris, Martin Kaiser, Heather Landau, Jean-Marie Michot, Luisa Veronese, Martina Makrutzki, Susan Francis Lasserre, Igor Puzanov, Jose Baselga

Blood (2015) 126 (23): 4263.

https://doi.org/10.1182/blood.V126.23.4263.4263

Published: 2015

Journal Articles

Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII

Andrew Yee, Austin N. Oleskie, Anne M. Dosey, Colin A. Kretz, Robert D. Gildersleeve, Somnath Dutta, Min Su, David Ginsburg, Georgios Skiniotis

Blood (2015) 126 (8): 939–942.

https://doi.org/10.1182/blood-2015-04-641696

Published: 2015

Includes: Supplemental data

Journal Articles

A von Willebrand factor fragment containing the D′D3 domains is sufficient to stabilize coagulation factor VIII in mice

Andrew Yee, Robert D. Gildersleeve, Shufang Gu, Colin A. Kretz, Beth M. McGee, Keisha M. Carr, Steven W. Pipe, David Ginsburg

Blood (2014) 124 (3): 445–452.

https://doi.org/10.1182/blood-2013-11-540534

Published: 2014

Includes: Supplemental data

Journal Articles

ACY-1215, a Selective Histone Deacetylase (HDAC) 6 Inhibitor, In Combination With Lenalidomide and Dexamethasone (dex), Is Well Tolerated Without Dose Limiting Toxicity (DLT) In Patients (Pts) With Multiple Myeloma (MM) At Doses Demonstrating Biologic Activity: Interim Results Of a Phase 1b Trial

Andrew Yee, Peter Vorhees, MD, William I. Bensinger, MD, Jesus Berdeja, MD, Jeffrey G Supko, PhD, Paul G. Richardson, MD, Simon S Jones, PhD, Gretchen Patrick, Catherine Wheeler, MD, Noopur Raje, MD

Blood (2013) 122 (21): 3190.

https://doi.org/10.1182/blood.V122.21.3190.3190

Published: 2013

Journal Articles

Combinational Therapy of Lenalidomide with Activin A Neutralizing Antibody; Preclinical Rationale for a Novel Anti-Myeloma Strategy

Tyler Scullen, Sonia Vallet, Loredana Santo, Mariateresa Fulciniti, PhD, Homare Eda, Diana D. Cirstea, MD, Kishan Patel, Andrew Yee, Anuj Mahindra, MD, Noopur Raje, MD

Blood (2012) 120 (21): 1871.

https://doi.org/10.1182/blood.V120.21.1871.1871

Published: 2012

Journal Articles

Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate Therapy

Chirayu Patel, Andrew Yee, Tyler A. Scullen, Neeharika Nemani, Loredana Santo, Anuj Mahindra, Paul G. Richardson, MD, Jacob P. Laubach, MD, Irene M. Ghobrial, MD, Robert Schlossman, MD, Kenneth C. Anderson, Nikhil C Munshi, MD, Noopur Raje

Blood (2012) 120 (21): 3965.

https://doi.org/10.1182/blood.V120.21.3965.3965

Published: 2012

Journal Articles

Mutational Profiling of Multiple Myeloma Bone Marrow Aspirates As a Clinical Tool for Personalized Treatment of Myeloma

Anuj Mahindra, MD, Dora Dias-Santagata, Ph.D., Darrell Borger, Ph.D., Loredana Santo, Tyler A. Scullen, Andrew Yee, Homare Eda, Diana Cirstea, Anthony John Iafrate, M.D., Ph.D., Noopur Raje, MD

Blood (2012) 120 (21): 3990.

https://doi.org/10.1182/blood.V120.21.3990.3990

Published: 2012

Journal Articles

Rational Combination Treatment of a Novel Selective mTOR Kinase Inhibitor AZD8055 with IGF-1R Inhibitors in Multiple Myeloma

Diana Cirstea, Teru Hideshima, MD, PhD, Loredana Santo, Homare Eda, Tyler A. Scullen, Neeharika Nemani, Anuj Mahindra, Andrew Yee, Yiguo Hu, Naoya Mimura, Jiro Minami, Hiroto Ohguchi, Rikio Suzuki, Francesca Cottini, Sylvie M Guichard, Kenneth C. Anderson, Noopur Raje

Blood (2012) 120 (21): 4023.

https://doi.org/10.1182/blood.V120.21.4023.4023

Published: 2012

Journal Articles

Partial in Vivo FVIII Stabilization by VWF Fragments

Andrew Yee, PhD, Austin N Oleskie, Robert D Gildersleeve, Colin A Kretz, PhD, Min Su, PhD, Beth M McGee, Keisha M Carr, Georgios Skiniotis, PhD, David Ginsburg, MD

Blood (2012) 120 (21): 15.

https://doi.org/10.1182/blood.V120.21.15.15

Published: 2012

NARROW

Tissue Kallikrein 1 and Alternative Complement Pathway Activation in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Functional Assessment of VWD Type 2N Variants Using Mammalian Cell Displayed Surface-Tethered Von Willebrand Factor

Keeping it together

Phage Display Functionally Defines Variants in the Von Willebrand Factor Platelet Binding Domain

Development of Platforms to Phenotype Variants of Uncertain Significance in VWF

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Comprehensive Genetic Interrogation of Circulating Multiple Myeloma Cells at Single Cell Resolution

Vemurafenib (VEM) in Relapsed Refractory Multiple Myeloma Harboring BRAF V600 Mutations (V600m): A Cohort of the Histology-Independent VE-Basket Study

Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII

A von Willebrand factor fragment containing the D′D3 domains is sufficient to stabilize coagulation factor VIII in mice

ACY-1215, a Selective Histone Deacetylase (HDAC) 6 Inhibitor, In Combination With Lenalidomide and Dexamethasone (dex), Is Well Tolerated Without Dose Limiting Toxicity (DLT) In Patients (Pts) With Multiple Myeloma (MM) At Doses Demonstrating Biologic Activity: Interim Results Of a Phase 1b Trial

Combinational Therapy of Lenalidomide with Activin A Neutralizing Antibody; Preclinical Rationale for a Novel Anti-Myeloma Strategy

Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate Therapy

Mutational Profiling of Multiple Myeloma Bone Marrow Aspirates As a Clinical Tool for Personalized Treatment of Myeloma

Rational Combination Treatment of a Novel Selective mTOR Kinase Inhibitor AZD8055 with IGF-1R Inhibitors in Multiple Myeloma

Partial in Vivo FVIII Stabilization by VWF Fragments

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only